Form 4 Tracker
Serge Saxonov

Director, Chief Executive Officer · 12 filings · Latest: Sep 22, 2026

10x Genomics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TXG
Serge SaxonovDirector, Chief Executive OfficerSep 22, 2026
Sale
$81.2225,000$2.0M1,050,249
TXG
Serge SaxonovDirector, Chief Executive OfficerAug 26, 2026
Sale
$63.6910,486$667.9K1,075,349
TXG
Serge Saxonov—Aug 26, 2026
Proposed Sale
$62.1835,486$2.2M—
TXG
Serge SaxonovDirector, Chief Executive OfficerAug 24, 2026
Sale
$63.0218,545$1.2M1,085,835
TXG
Saxonov Serge—Aug 24, 2026
Proposed Sale
$65.1217,948$1.2M—
TXG
Serge SaxonovDirector, Chief Executive OfficerJun 22, 2026
Sale
$34.4430,000$1.0M1,108,380
TXG
Serge SaxonovDirector, Chief Executive OfficerMay 26, 2026
Sale
$24.7110,718$264.8K1,138,380
TXG
Serge SaxonovDirector, Chief Executive OfficerMay 22, 2026
Sale
$24.4418,175$444.2K1,149,098
TXG
Serge Saxonov—May 26, 2026
Proposed Sale
$23.6840,718$964.2K—
TXG
Saxonov Serge—May 22, 2026
Proposed Sale
$24.6817,948$443.0K—
TXG
Serge SaxonovDirector, Chief Executive OfficerApr 14, 2026
Sale
$24.565,000$122.8K1,167,273
TXG
Serge SaxonovDirector, Chief Executive OfficerMar 24, 2026
Sale
$19.525,000$97.6K1,172,273
TXG
Serge SaxonovDirector, Chief Executive OfficerMar 23, 2026
Sale
$19.1310,000$191.3K1,177,273
TXG
Serge SaxonovDirector, Chief Executive OfficerMar 2, 2026
Sale
$22.7316,152$367.1K1,203,667
TXG
Serge Saxonov—Mar 2, 2026
Proposed Sale
$22.1341,152$910.7K—
TXG
Serge SaxonovDirector, Chief Executive OfficerFeb 23, 2026
Sale
$18.589,632$178.9K1,061,924
TXG
Saxonov Serge—Feb 23, 2026
Proposed Sale
$19.1910,129$194.4K—
TXG
Saxonov Serge—Nov 24, 2025
Proposed Sale
$18.3413,096$240.2K—
TXG
Saxonov Serge—Aug 22, 2025
Proposed Sale
$13.419,228$123.7K—
TXG
Saxonov Serge—May 22, 2025
Proposed Sale
$9.089,227$83.8K—

Page 1 of 2

Next →